HUTCHMED (LON:HCM) Stock Price Crosses Below 200-Day Moving Average – Here’s What Happened

HUTCHMED (China) Limited (LON:HCM)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 289.99 ($3.65) and traded as low as GBX 261 ($3.29). HUTCHMED shares last traded at GBX 264 ($3.33), with a volume of 39,973 shares traded.

HUTCHMED Stock Performance

The business has a 50 day moving average of GBX 284.72 and a 200-day moving average of GBX 289.99. The company has a debt-to-equity ratio of 11.78, a quick ratio of 2.97 and a current ratio of 2.81. The company has a market capitalization of £2.26 billion, a P/E ratio of -6,600.00 and a beta of 0.76.

HUTCHMED Company Profile

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors.